Abbott Laboratories Limited

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
Telephone: +44 (0)1628 773 355
Fax: +44 (0)1628 644 185
WWW: http://www.abbottuk.com
Medical Information e-mail: ukmedinfo@abbott.com
Out of Hours Telephone: +44 (0)1628 774 920

Patient Information Leaflet last updated on the eMC: 15/08/2011
PIL Kaletra 100mg/25mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Change to dosage and administration
  • Extra statutory information
Updated on 16/11/2010 and displayed until 15/08/2011
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
  • Change to side-effects
Updated on 04/06/2010 and displayed until 16/11/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
  • Change to side-effects
  • Changes to therapeutic indications
Updated on 06/01/2010 and displayed until 04/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to MA holder contact details
Updated on 24/09/2009 and displayed until 06/01/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 25/09/2008 and displayed until 24/09/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 30/05/2008 and displayed until 25/09/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   ritonavir
   lopinavir